Reconstructive Surgery

Mariotti, Carlo; Bianchelli, Gabriele; Riccio, Michele; Aquinati, Angelica; Sebastiani, Elisa

doi:10.1007/978-88-470-5438-7_16

Cited by 1 publication

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Atypical ductal hyperplasia is associated with a 4-5 times relative risk of developing breast cancer in the ensuing 10 to 15 years after the diagnosis. [7][8][9]…”

Section: Introductionmentioning

confidence: 99%

Fibrocystic Breast Tumor: A Case Report

Kalitouw

Manginstar

Siwabessy

2023

MSJ

View full text Add to dashboard Cite

Fibrocystic breast tumor is the most common benign type of breast diseases that affects millions of women worldwide. Fibrocystic breast changes are classified as non-proliferative, proliferative without atypia, or proliferative with atypia. We reported a 34-year-old woman presented with a right breast evaluation of breast tumors since one year before admission. On examination, a solid and hard breast tumor measuring 15x10 cm was palpable, well-defined, tender, mobile, and no nipple discharge. The patient underwent two times of core biopsy and the results were fibrocystic changes. Although clinically the breast tumor had a malignant appearance, but the results of core biopsy examinations revealed fibrocystic changes. The patient was managed by wide excision of the evaluated breast tumor with preservation of the breast skin and nipple areolar complex to maintain its function and aesthetic. In conclusion, evaluation of breast tumors must go through a triple diagnostic procedure namely clinical, imaging, and histopathological examinations. Fibrocystic breast tumor can be managed with wide excision of the tumor with preservation of the skin structure and nipple areolar complex of the breast to achieve a natural aesthetic. Keywords: fibrocystic breast tumor; wide excision of tumor; evaluation of breast tumors

show abstract

“…Atypical ductal hyperplasia is associated with a 4-5 times relative risk of developing breast cancer in the ensuing 10 to 15 years after the diagnosis. [7][8][9]…”

Section: Introductionmentioning

confidence: 99%